Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.
about
Menopause, obesity and inflammation: interactive risk factors for Alzheimer's diseasePro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cellsMinocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor- alphaEffect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonistsThe role of inflammasome in Alzheimer's diseasemiR-155 is involved in Alzheimer's disease by regulating T lymphocyte functionInflammation and Alzheimer's diseaseInterleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's diseaseCharacterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain.Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse modelNeural activities of IL-6-type cytokines often depend on soluble cytokine receptors.Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells.Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model.The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk.Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapyProtection against murine leukemia virus-induced spongiform myeloencephalopathy in mice overexpressing Bcl-2 but not in mice deficient for interleukin-6, inducible nitric oxide synthetase, ICE, Fas, Fas ligand, or TNF-R1 genesMicroglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.Pharmacotherapy in the treatment of Alzheimer's disease: an updateInflammatory processes induce beta-amyloid precursor protein changes in mouse brain.Are there roles for brain cell senescence in aging and neurodegenerative disorders?Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?Rapid induction of tumor necrosis factor alpha in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay.The classification of microglial activation phenotypes on neurodegeneration and regeneration in Alzheimer's disease brain.Isoprenoids and related pharmacological interventions: potential application in Alzheimer's disease.C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line.Microglia in Alzheimer brain: a neuropathological perspective.Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain.Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotypeThe role of pleiotropic effects of statins in dementia.Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease.The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study.Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulationS100beta induction of the proinflammatory cytokine interleukin-6 in neurons.Neuroinflammation and brain functional disconnection in Alzheimer's disease.Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease.Glial cytokines in Alzheimer's disease: review and pathogenic implicationsGenomics of immune molecules: early detection of cognitive decline and new therapeutic interventions.
P2860
Q21131065-5DEECF2A-3FE1-4080-8800-7CC392AE9670Q21245229-C6F07E9E-441C-4D8F-9E8C-F37DC3FEACD3Q23916369-9AC605CE-248D-48C2-B58B-C11498F40E0BQ24310711-9EDD01CE-B055-4031-A9A1-2BFE933D491AQ26996822-7023A0FD-2CB3-4979-A49E-E7443E009CD7Q28087564-F9EBA86B-482F-47B5-BA24-741A798056B9Q28138617-0F61FD16-27F3-464D-B985-59C02F7E8E4CQ28216434-45BFA386-04C0-4661-9FA1-7BFF477153E1Q30438850-9FBF32C2-0522-4220-940A-8C9D42BDA07DQ30667424-F1E0B897-CEFA-4E59-8E16-810A42DD4CD6Q33746118-1D348532-B0D4-4454-B801-0465A5F9FA39Q33798898-CFACA3FE-F72B-4FB0-BCFA-31A11E3AE4E3Q33810933-01207DC4-F159-45F2-AFEA-AF21B67C2A87Q34013763-7BC8E6DF-DDF7-48ED-AD5B-DC954B0B3B3EQ34219814-FFC3670F-53DE-4119-A62B-63980FBFDA9FQ34227192-54A907C8-1F15-48A7-A10D-4C9BE8915A0AQ34309544-974FFE26-BDD9-4FD5-A9C5-EEBA2DA52BEEQ34481842-0F2931A0-3593-46A6-A88F-4A9622159334Q34531006-64B4D71D-025B-4617-AC1C-367639D484C0Q34688159-8A1C023A-DF22-4702-B03F-AF0CDB0D4233Q34771671-5AF65594-9ED0-45D5-8C93-4E09612F6E79Q34853793-313EEDD0-F9FA-4C5E-AA52-F3A5CD52DA7BQ35599843-D4FE0207-90A6-465C-BDD7-25F13E336A15Q35634151-2EABD647-DE62-4887-A961-FB17A9BD22CFQ35748268-37DEBB9E-7980-45C0-B2FE-4298698308A5Q35986371-255CF97D-A89F-403E-82B6-1F321EE9EC80Q35998206-A04E7DA1-4345-4143-A18B-A5974FF9B68AQ36197138-668794D2-BF3D-45E9-B8F6-7A11C06B4E75Q36546539-7F75B81C-30D6-4EAA-8C4E-1660A862D50BQ36631212-B8341049-CD9E-488C-B719-94CFFF3E43E2Q36961152-EEC13C0E-B520-480A-A834-5CB59577441CQ37067641-518D52F8-CD92-47F1-98FF-1BFF32C0DA4FQ37068847-258C7775-AF47-4495-88DA-EF035220CE14Q37131312-BEBD9B52-D6F8-4BC4-942E-C4EB345DC0AAQ37220361-DC4D8829-E20F-4A93-975F-32677FA6FE11Q37332541-38BE8299-6434-45CA-A890-E4D1564390ACQ37338892-9EBE9E8F-7AFE-4BAC-A119-3DE665E659CEQ37348489-9C895726-6A04-48B3-970A-B32FAEBA43DFQ37520360-8666A749-A186-4EAA-B075-643FA2B912DFQ37610265-6C70719B-9437-4727-910A-2DA22D9783F0
P2860
Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Interleukin-6 and alpha-2-macr ...... Alzheimer's disease cortices.
@en
Interleukin-6 and alpha-2-macr ...... Alzheimer's disease cortices.
@nl
type
label
Interleukin-6 and alpha-2-macr ...... Alzheimer's disease cortices.
@en
Interleukin-6 and alpha-2-macr ...... Alzheimer's disease cortices.
@nl
prefLabel
Interleukin-6 and alpha-2-macr ...... Alzheimer's disease cortices.
@en
Interleukin-6 and alpha-2-macr ...... Alzheimer's disease cortices.
@nl
P2093
P1433
P1476
Interleukin-6 and alpha-2-macr ...... Alzheimer's disease cortices.
@en
P2093
Schlegel P
Schreiter-Gasser U
P304
P356
10.1016/0014-5793(91)80737-N
P407
P577
1991-07-01T00:00:00Z